HeartMate 3 LVAD

With Full Maglev Flow Technology

HeartMate 3 LVAD

HeartMate 3 LVAD Patient Education

Patients with advanced heart failure may not fully grasp that heart failure is a serious, progressive disease. They may not realize how sick they truly are until it’s too late.

You can help your patients understand if HeartMate 3™ LVAD therapy might be a treatment option before their heart failure progresses, giving them more time to decide and plan for their heart failure treatment.

Here are a few points you might want to share with your patients:

  • LVAD therapy is an option for patients with NYHA Class IIIB-IV heart failure
  • HeartMate 3 LVAD is a small implantable pump that is designed to help their heart pump blood
  • There have been significant clinical advancements in LVAD therapy, with HeartMate 3 LVAD survival rate now comparable to heart transplant at 2 years1,2*
  • HeartMate 3 LVAD has an excellent safety profile, with reduced stroke and pump thrombosis adverse events rates3

Receive more information about how the HeartMate 3 LVAD can help your advanced heart failure patients.

Resources to Support LVAD Patient Education & Discussion

Live a More Active Life with an LVAD

 

Review fast facts and helpful information about living life with a HeartMate 3 LVAD.

HeartMate 3 LVAD Patient brochure

HeartMate 3 Left Ventricular Assist Device (LVAD) Patient Guide


This guide helps patients and caregivers become familiar with the HeartMate 3 LVAD upon hospital discharge.

Cover of HeartMate 3 Patient Guide with an older adult man and woman.

HeartMate 3 LVAD Patient Education Handbook

This guide, created by the Advanced Cardiac Therapies Improving Outcomes Network (ACTION), is an easy-to-read education reference and scrapbook for patients to use on their LVAD journey​.

Cover of HeartMate 3 Educational Reference Guide

Patient Education videos for understanding the HeartMate 3 LVAD pre-implant and post-implant.

Patient education videos
 Find a HeartMate 3 LVAD Center

Find a HeartMate 3 LVAD Center

 HeartMate 3 Patient Information

HeartMate 3 Patient Information

 Customer Service

Customer Service

*Based on published data from separate datasets, which may involve different patient populations and other variables. Not a head-to-head comparison. Data presented for informational purposes only.

References

  1. Teuteberg JJ, Cleveland JC, Cowger J, Higgins RS, et al. The Society of Thoracic Surgeons Intermacs 2019 Annual Report: the changing landscape of devices and indications. Ann Thorac Surg. 2020;109:649-660.
  2. Khush KK, Cherikh WS, Chambers DC, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth Adult Heart Transplant Report-2018: Focus Theme: Multiorgan Transplantation. J Heart Lung Transplant 2018:37:1155-1168.
  3. Mehra MR, Goldstein DJ, Cleveland JC, et al. Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial. JAMA. September 8, 2022.

MAT-2012376 v5.0